SEC Form 4 · accession 0001209191-16-155808
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bakker Juliet Tammenoms
10% Owner
Period of report
Dec 15, 2016
Accepted (ET)
Dec 19, 2016 · 1:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2016 | G | 70,671 | $0.00 | D | 133,539 | D | |
| Common StockF1 | holding | — | — | — | 10,740,720 | I | By LVP | |
| Common StockF1 | holding | — | — | — | 215,282 | I | By LCA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Ms. Bakker is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Ms. Bakker disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of her pecuniary interest therein.